You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • AB1392 Predictors of work impairment in a randomized controlled trial of etanercept-methotrexate therapy in patients with moderate rheumatoid arthritis

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Abstracts accepted for publication
Epidemiology, health services and outcome research
AB1392 Predictors of work impairment in a randomized controlled trial of etanercept-methotrexate therapy in patients with moderate rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014300
Mar 2014900
Apr 2014200
May 2014200
Jun 2014100
Jul 2014100
Aug 2014101
Sep 2014200
Oct 2014200
Nov 2014500
Dec 2014200
Jan 2015300
Feb 2015100
Mar 2015200
Apr 2015300
May 2015101
Jul 2015400
Aug 2015500
Sep 20152507
Oct 2015301
Nov 2015500
Dec 2015901
Jan 2016600
Feb 2016900
Mar 20161003
Apr 2016903
May 2016400
Jun 2016400
Jul 2016400
Aug 2016700
Sep 2016601
Oct 2016500
Nov 2016500
Dec 2016300
Jan 2017501
Feb 2017200
Mar 20171001
Apr 2017600
May 2017700
Jun 2017500
Jul 20172301
Aug 20173200
Sep 20171600
Oct 20171000
Nov 20171000
Dec 20171000
Jan 20181200
Feb 2018400
Mar 2018400
Apr 20181800
May 20181801
Jun 20181201
Jul 2018800
Aug 2018400
Sep 2018400
Oct 2018600
Nov 2018200
Dec 2018400
Jan 2019602
Feb 2019600
Mar 2019600
Apr 2019200
Jul 2019300
Sep 2019200
Oct 2019200
Nov 20191001
Dec 2019800
Feb 2020500
Apr 20201802
May 2020300
Jun 2020400
Jul 2020600
Aug 2020100
Sep 20201101
Oct 2020402
Nov 2020700
Dec 2020600
Jan 2021200
Feb 2021200
Mar 2021500
Apr 2021600
Jun 2021400
Aug 2021200
Oct 2021500
Nov 2021801
Dec 20211100
Jan 2022800
Feb 2022800
Mar 2022600
May 2022800
Jun 2022200
Jul 20221800
Aug 2022800
Sep 2022600
Oct 2022400
Nov 20221200
Dec 20221000
Jan 2023400
Feb 2023400
Mar 20231000
Apr 2023600
May 2023200
Jul 2023601
Aug 2023200
Sep 2023800
Oct 2023200
Nov 2023400
Dec 20231800
Jan 20241400
Feb 2024200
Mar 2024200
Total724033